SIBIONICS Showcases AI-Powered GS3 Glucose Monitoring, Advances Integrated Diabetes Care at Melbourne Congress ...

The pharmaceutical services major increases its interim shareholder payout from RMB 1.03 billion in 2025, while continuing to ...

Data4Life and Monash Health have partnered to optimize clinical trial design and execution, complemented by educational ...

- Topline data from the AURORA Phase III clinical program are expected in the third quarter of 2028, with a U.S. Food and ...

Thermo Fisher Scientific is reinforcing its commitment to China as the country emerges as an increasingly important source of ...

METHOD IN BRIEF Cost-of-goods figures in this article are reconstructions, not disclosures. No company supplied a ...

DUALITYBIO Inc. announced that it has entered into a collaboration and license agreement with Genentech, a member of the ...

In July, Samsung Biologics announced an all-cash offer to acquire PolyPeptide Group for CHF 1.46 billion (approximately KRW 2 ...

Pivotal trial will evaluate the HER2-targeted ADC biosimilar against Roche’s Kadcyla, advancing Formosa Pharmaceuticals and ...

Sanyou Biopharmaceuticals Co., Ltd. (hereinafter referred to as "Sanyou Bio"), announced the official launch of Clicklinks, ...

Memorandum of Understanding establishes a framework for joint development of clinical trial simulation capabilities; The ...

Designation supports the global development of RTX-117 and may provide potential future access to a transferable Priority ...